Clinical Trials
6
Active:0
Completed:2
Trial Phases
3 Phases
Phase 2:2
Phase 3:1
Phase 4:3
Drug Approvals
7
NMPA:4
PHILIPPINES:3
Drug Approvals
Levothyroxine Sodium Tablets
- Product Name
- 左甲状腺素钠片
- Approval Number
- 国药准字HJ20240061
- Approval Date
- Jun 28, 2024
NMPA
Levothyroxine Sodium Tablets
- Product Name
- 左甲状腺素钠片
- Approval Number
- 国药准字HJ20240062
- Approval Date
- Jun 28, 2024
NMPA
Levothyroxine Sodium Tablets
- Product Name
- 左甲状腺素钠片
- Approval Number
- 国药准字HJ20240060
- Approval Date
- Jun 28, 2024
NMPA
Levothyroxine Sodium Tablets
- Product Name
- 左甲状腺素钠片
- Approval Number
- 国药准字HJ20240063
- Approval Date
- Jun 28, 2024
NMPA
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Phase 4
3 (50.0%)Phase 2
2 (33.3%)Phase 3
1 (16.7%)Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection
Phase 2
Terminated
- Conditions
- Pulmonary InfectionCovid-19
- Interventions
- Drug: Placebo
- First Posted Date
- 2020-04-16
- Last Posted Date
- 2021-09-23
- Target Recruit Count
- 5
- Registration Number
- NCT04348513
- Locations
- 🇬🇷
Attikon University General Hospital, Haidari/Athens, Greece
Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial
Phase 2
Terminated
- Conditions
- Pneumonia, ViralCovid-19
- Interventions
- Drug: UNIKINON (Chloroquine phosphate) 200mg tablets
- First Posted Date
- 2020-04-14
- Last Posted Date
- 2021-09-23
- Target Recruit Count
- 29
- Registration Number
- NCT04344951
- Locations
- 🇬🇷
Divine Providence Hospital "Pammakaristos", Athens, Greece
🇬🇷Athens General Hospital "Hippokrateio", Athens, Greece
🇬🇷Athens General Hospital of Thoracic Diseases "SOTIRIA", 1st University Pulmonary Clinic, Athens, Greece
Ferrous Acetyl-Aspartate Casein Formulation Evaluation Over Ferrous Sulfate in Iron Deficiency Anemia
- First Posted Date
- 2018-05-15
- Last Posted Date
- 2021-04-09
- Target Recruit Count
- 60
- Registration Number
- NCT03524651
- Locations
- 🇬🇷
General Hospital of Athens G. Gennimatas, Athens, Greece
🇬🇷Attikon University Hospital, Haidari/Athens, Greece
🇬🇷Amalia Fleming Prefecture General Hospital of Melissia, Melíssia, Greece
A New Formulation of Intravenous Paracetamol for Fever Management
Phase 4
Completed
- Conditions
- Fever
- Interventions
- Drug: APOTEL maxDrug: Placebo
- First Posted Date
- 2014-11-05
- Last Posted Date
- 2016-03-22
- Target Recruit Count
- 80
- Registration Number
- NCT02283203
- Locations
- 🇬🇷
General Hospital of Chalkida, Chalkida, Greece
🇬🇷Attikon Hospital, Haidari/Athens, Greece
🇬🇷University Hospital of Crete, Herakleion, Greece
News
No news found